CAM
TMO icon

Cidel Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Cidel Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
2,183
+129
+6% +$61.9K 0.05% 162
2026
Q1 		$1.01M Buy
2,054
+404
+24% +$219K 0.06% 151
2025
Q4 		$956K Sell
1,650
-43
-3% -$24.3K 0.07% 135
2025
Q3 		$821K Buy
1,693
+133
+9% +$61.9K 0.05% 143
2025
Q2 		$633K Buy
1,560
+191
+14% +$79.9K 0.04% 172
2025
Q1 		$681K Buy
1,369
+56
+4% +$30.3K 0.04% 154
2024
Q4 		$683K Buy
1,313
+38
+3% +$20.9K 0.05% 157
2024
Q3 		$789K Buy
1,275
+53
+4% +$31.4K 0.06% 140
2024
Q2 		$676K Buy
1,222
+38
+3% +$21.8K 0.05% 146
2024
Q1 		$688K Sell
1,184
-149
-11% -$83.6K 0.05% 151
2023
Q4 		$708K Sell
1,333
-39,577
-97% -$19.2M 0.03% 148
2023
Q3 		$20.7M Sell
40,910
-51
-0.1% -$27.2K 1.04% 32
2023
Q2 		$21.4M Buy
40,961
+2,540
+7% +$1.37M 0.97% 34
2023
Q1 		$22.1M Buy
38,421
+173
+0.5% +$97.5K 1.02% 34
2022
Q4 		$21.1M Sell
38,248
-379
-1% -$201K 0.99% 35
2022
Q3 		$19.6M Buy
+38,627
New +$21.6M 0.93% 37

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Cidel Asset Management's TMO Position: Q2 2026 in Review

Cidel Asset Management increased its Thermo Fisher Scientific (TMO) stake by 6.3% in Q2 2026, buying an estimated $61.9K and bringing the position to 2,183 shares worth $1.09M. The position accounts for 0.05% of the portfolio, ranked #162.

Cidel Asset Management first reported a position in TMO in Q3 2022 and has held it in 16 quarters since. The position peaked at $22.1M in Q1 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cidel Asset Management held 2,183 shares of Thermo Fisher Scientific worth $1.09M as of Q2 2026.
  • Cidel Asset Management bought 129 Thermo Fisher Scientific shares in Q2 2026, an estimated $61.9K.
  • Thermo Fisher Scientific made up 0.05% of Cidel Asset Management's portfolio in Q2 2026, its #162 holding.
  • Cidel Asset Management first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 16 quarters since.
  • Cidel Asset Management's Thermo Fisher Scientific position peaked at $22.1M in Q1 2023.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.